CancerCare Manitoba Foundation presents several significant fundraising events each year. By supporting as a sponsor, volunteer, participant, or donor in any of these events, you contribute to the Foundation’s efforts to raise essential funds that support the crucial work at CancerCare Manitoba.
Guardian Angel Benefit for Cancers Impacting Women
On October 4, in keeping with tradition, the 35th annual benefit will showcase a fashion show featuring special guest models and live entertainment. All funds raised from the Guardian Angel Benefit will remain in Manitoba, providing support for women who will confront a life-altering cancer diagnosis—both now and in the future. The proceeds of this event will aid in research, clinical trials, and will ensure the highest quality of physical and emotional care.
Ride Inside for Pediatric Cancers
Join us for a stationary bike celebration filled with family, friends, and fundraising excitement! The funds raised will significantly impact children with cancer in Manitoba. Each year, around 50 to 60 families in the province receive the heartbreaking news that their child has cancer. With your support, these families will have a greater chance for a positive outcome.
A Gold-Plated Evening for Men’s Cancers
A Gold-Plated Evening is a distinguished event hosted by the Foundation every two years, complete with a dinner and live entertainment. The next Gold-Plated Evening is scheduled for 2027. We invite you to join us in uniting to support Manitoban men in their battle against cancer.
Challenge for Life for all Cancers
Thanks to the efforts of 1,202 participants, more than 350 volunteers, generous sponsors and 8,300 donors from across Manitoba and beyond, a record-breaking $3,137,882 was raised at Challenge for Life 2026 in support of CancerCare Manitoba and, most importantly, the thousands of Manitobans impacted by a cancer diagnosis. Since 2008, Challenge for Life participants, donors, sponsors and volunteers have raised more than $23 million in support of Manitobans affected by cancer.